(March 21 04:49) Forbes.com Business
$4.2 billion synthetic biology powerhouse Ginkgo Bioworks is giving $25 million worth of resources in their $400 million R&D facility to public and private teams working to cure, prevent and treat the novel coronavirus.
You can find the original article
here